<DOC>
	<DOCNO>NCT02081092</DOCNO>
	<brief_summary>The purpose study twofold : ass routine cat scan ( CT ) image biomarker removal lipoprotein surfactant via lung lavage ( CT gold-standard imaging technique density quantification ) , utilize novel UTE MRI protocol similarly quantify surfactant removal . This study also serve generate baseline scanning may aid develop analytical tool evaluate treat specific lung region patient PAP .</brief_summary>
	<brief_title>Evaluation Treatment Planning Patients With PAP Using Thrive Ultra Short Echo Time MRI CT</brief_title>
	<detailed_description>This study evaluate x-ray CT biomarker surfactant lavage removal evaluate UTE-Thrive MRI protocol CCHMC image alternative CT . Potential subject meet study criterion identify Pulmonary physician Cincinnati Children 's Hospital Medical Center ( CCHMC ) University Cincinnati ( UC ) clinic patient . The study include two research MRIs ( one pre lavage second 24 72 hour first lung lavage ) clinical CT perform pre lavage , one research CT also perform second research MRI . All image analysis quantitative . Whole-lung regional density calculate evaluated lung lavage , quantification change density leave lung right lung separately . Since one lung serve control , allow precise error estimation ( expect quite small largely related difference lung volume ) . One purpose protocol refine develop ultra-short echo time ( UTE ) MRI technique since Pulmonary Alveolar Proteinosis ( PAP ) patient may multiple lavage session per year . A subject may eligible re-enroll participate multiple time total number research CTs enrollments one less subject .</detailed_description>
	<mesh_term>Pulmonary Alveolar Proteinosis</mesh_term>
	<criteria>Clinically diagnose PAP schedule lung lavage double lumen endoscopy . Children patient ≥ 8 year age Adult patient ≤ 75 year age Medically stable per opinion Bruce Trapnell , MD Robert Wood , MD Patient parent consent obtain Standard MRI exclusion criterion set forth CCHMC Division Radiology Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>PAP</keyword>
	<keyword>Pulmonary Alveolar Proteinosis</keyword>
	<keyword>Pulmonary</keyword>
	<keyword>Patients</keyword>
</DOC>